It should be pointed out that during the time of its development, the role of different VEGF isoforms in ARMD was incompletely understood and pegaptanib was specifically selected to bind the VEGF165 isoform, whereas both antibodies additionally bind the VEGF121 isoform 199. Here, VEGFA is linked to age-related macular degeneration.